Efficacy of IRC ablation of anal HSIL following observation in HIV-infected participants: AIDS Malignancy Trial 076

Efficacy of IRC ablation of anal HSIL following observation in HIV-infected participants: AIDS Malignancy Trial 076

Background: Anal HSIL ablation may reduce the incidence of invasive cancer, but few data exist on treatment efficacy in patients with delayed treatment after observation. Methods: A multisite clinical trial of HIV-positive participants (≥27 years old) with 1–3 biopsy-proven anal HSIL randomized to I...

Full description

Bibliographic Details
Main Authors: Stephen E. Goldstone, MD FACS, Shelly Y. Lensing, MA, Elizabeth A. Stier, M, Timothy Wilkin, MD, AIDS Malignancy Consortium HPV Working Group.
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Papillomavirus Research
Online Access:http://www.sciencedirect.com/science/article/pii/S2405852118300582

Similar Items

Similar Items